Up next


NYU Study finds patients given Hydroxychloroquine + Zinc 44% less likely to die from COVID-19

buckthesystem
buckthesystem - 156 Views
25
156 Views
Published on 18 May 2020 / In Film and Animation

Researchers at NYU's Grossman School of Medicine found patients given the antimalarial drug hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus.

Show more
0 Comments sort Sort by

Up next